全球微創手術市場規模（依手術類型、產品類型、應用、區域範圍和預測）

微創手術（MIS）市場規模及預測

2024 年微創手術市場規模價值 224 億美元，預計到 2032 年將達到 355 億美元，2026 年至 2032 年的複合年成長率為 10.5%。

微創手術 (MIS) 是一種旨在達到與傳統開放性手術相同效果，但對身體創傷較小的手術技術。此方法採用小切口、專用設備以及腹腔鏡和內視鏡等先進技術，使外科醫生無需進行大切口即可觀察和操作內部組織。 MIS 的主要優點是術後不適感更少、住院時間更短、癒合時間更快、疤痕更少。

微創手術應用於各科室，包括一般外科、整形外科、婦科、泌尿系統和循環系統。微創手術（MIS）的常見手術包括腹腔鏡膽囊切除術（膽囊切除術）、關節鏡手術、腹腔鏡子宮切除術和內視鏡鼻竇手術。隨著手術器械和影像技術的不斷發展，微創手術的應用範圍不斷擴大，能夠進行越來越複雜、精細的手術。

隨著技術的快速進步以及對以患者為中心的醫療護理的日益重視，微創手術 (MIS) 的未來預計將發生變革。其中最顯著的進步之一是將機器人技術和人工智慧 (AI) 融入外科手術中。機器人輔助手術正變得越來越普遍，為外科醫生提供了更高的精準度、靈活性和控制力，而這些對於透過小切口完成高難度手術至關重要。

全球微創手術市場動態

影響全球微創手術市場的關鍵市場動態是：

關鍵市場促進因素

患者獲益和療效：採用微創手術 (MIS) 的主要原因之一是，與開放性手術相比，MIS 術後疼痛更少、感染疾病風險更低、住院時間更短、恢復更快。這些優勢有助於提高患者滿意度和整體治療效果。腹腔鏡膽囊切除術（膽囊切除術）和微創心血管手術等手術對患者周圍組織的損傷較小，使他們能夠更快康復並恢復正常活動。

技術進步：醫療技術的快速發展極大地促進了微創手術（MIS）的發展。高解析度攝影機、微型手術器械、機器人輔助手術系統（例如達文西手術系統）以及先進的影像技術（例如腹腔鏡超音波和術中核磁共振成像）使外科醫生能夠透過小切口以更高的精度和控制力執行複雜的手術。

降低醫療成本：微創手術已證明具有為醫療系統和患者節省成本的潛力。儘管微創手術技術相關的初始資本成本可能較高，但最終的成本效益體現在縮短住院時間、減少手術併發症、減少後續觀察以及加快復原時間。從長遠來看，這些因素有助於降低醫療成本並提高資源利用率。

主要挑戰

技術專長和訓練要求：微創手術 (MIS) 的關鍵問題之一是獲得必要技能和能力所需的學習曲線較高。外科醫生需要經過特殊培訓，具備使用內視鏡和機器人器械透過小切口進行手術的技能。 MIS 所需的技能和手眼協調能力通常與傳統開放性手術不同。

設備和器械成本：專用設備和器械的高昂成本限制了微創手術的普及。微創手術中使用的內視鏡、腹腔鏡器械、機器人系統和其他創新技術的購買、維護和升級成本高昂。醫療保健機構必須付出巨大努力才能獲得這些技術，這可能會造成財政資源緊張。

併發症風險與學習曲線：儘管微創手術 (MIS) 比傳統開放性手術併發症更少、恢復更快，但引入 MIS 並非沒有風險。 MIS 手術的學習曲線可能會導致術中問題增多，例如意外的器官損傷、出血以及轉為開放性手術。初入 MIS 領域的外科醫生可能會面臨難以透過小切口正確評估解剖結構以及處理術中意外觀察。

主要趨勢：

適應症不斷擴展：MIS 最初僅限於闌尾切除術和膽囊切除術等手術，如今已擴展到廣泛的外科專科。微創心血管手術(MICS)、微創脊椎手術和機器人輔助婦科手術等複雜手術已成為標準做法。針對特定解剖部位的專用設備和手術的發展，已將 MIS 的效用擴展到更廣泛的醫療狀況。

改善患者預後：改善患者預後是微創手術 (MIS) 的標誌，並持續推動其應用。對周圍組織的創傷更少、術後疼痛更少、恢復時間更快，所有這些都有助於縮短住院時間並降低醫療成本。與開放性手術相比，接受 MIS 的患者疤痕較少，傷口感染疾病風險較低。

培訓與教育隨著微創手術方法的不斷發展，培訓與教育已成為關注的重點。外科醫師需要接受專門培訓，才能掌握微創手術並熟練地運用技術創新。基於模擬的訓練計畫和虛擬實境 (VR) 模擬器正日益被廣泛使用，讓外科醫生在對患者實施手術前，在受控環境中獲得實踐經驗。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

4. 微創手術（MIS）市場（依手術類型）

• 腹腔鏡手術
• 機器人手術
• 內視鏡手術
• 胸腔鏡手術

第5章：微創手術（MIS）市場（依產品類型）

• 手術器械
• 機器人系統
• 視覺化系統
• 配件和耗材

第6章 微創手術（MIS）市場：依應用

• 胃腸外科
• 心臟外科手術
• 整形外科
• 婦科手術

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• Medtronic plc（Ireland）
• Johnson & Johnson（US）
• Stryker Corporation（US）
• Abbott Laboratories（US）
• Boston Scientific Corporation（US）
• Siemens Healthineers AG（Germany）
• Philips（Netherlands）
• GE Healthcare（US）
• Smith & Nephew plc（UK）
• Zimmer Biomet Holdings, Inc.（US）
• Olympus Corporation（Japan）
• Intuitive Surgical Inc.（US）（Focuses on robotic-assisted surgery）
• CONMED Corporation（US）
• B. Braun Melsungen AG（Germany）

第11章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Minimally Invasive Surgery (MIS) Market Size And Forecast

Minimally Invasive Surgery Market size was valued at USD 22.4 Billion in 2024 and is projected to reach USD 35.5 Billion by 2032, growing at a CAGR of 10.5% from 2026 to 2032.

Minimally invasive surgery (MIS) is a surgical method that tries to produce the same results as traditional open surgery but causing much less stress to the body. This method employs small incisions, specialized devices, and advanced technology such as laparoscopes and endoscopes allowing surgeons to observe and operate on interior tissues without the need for big incisions. The primary benefits of MIS are decreased postoperative discomfort, shorter hospital stays, faster healing times, and less scarring.

This surgery has numerous applications in a variety of medical specialties including general surgery, orthopedics, gynecology, urology, and cardiology. Common treatments performed with MIS techniques include laparoscopic cholecystectomy (gallbladder removal), arthroscopic joint surgeries, laparoscopic hysterectomy, and endoscopic sinus surgery. Continuous developments in surgical equipment and imaging technologies have broadened the possibilities for MIS allowing for increasingly intricate and delicate procedures.

The future of minimally invasive surgery (MIS) promises to be transformative because of rapid technological improvements and an increasing emphasis on patient-centered care. One of the most notable advancements is the incorporation of robotics and artificial intelligence (AI) into surgical procedures. Robotic-assisted operations are becoming increasingly common providing surgeons with more precision, dexterity, and control all of which are necessary for completing difficult procedures through small incisions.

Global Minimally Invasive Surgery Market Dynamics

The key market dynamics that are shaping the global minimally invasive surgery market include:

Key Market Drivers:

Patient Benefits and Outcomes: One of the key reasons for using MIS is that it provides patients with less postoperative pain, a lower risk of infection, shorter hospital stays, and faster recovery times than open operations. These benefits help to increase patient satisfaction and overall outcomes. Patients undergo less trauma to surrounding tissues during treatments such as laparoscopic cholecystectomy (gallbladder removal) or minimally invasive cardiac surgeries resulting in faster recovery and return to normal activities.

Technological Advancements: Rapid improvements in medical technology have contributed significantly to the growth of MIS. High-definition cameras, miniature surgical instruments, robotic-assisted surgery systems (such as the da Vinci Surgical System), and advanced imaging techniques (such as laparoscopic ultrasound and intraoperative MRI) have allowed surgeons to perform complex procedures more precisely and controllably through small incisions.

Reduced Healthcare Costs: Minimally invasive surgery has shown potential cost reductions for healthcare systems and patients alike. While the initial equipment expenses connected with MIS technology can be high, the eventual cost-effectiveness is demonstrated by shorter hospital stays, less surgical complications, fewer follow-up visits, and faster healing durations. In the long run, these variables contribute to lower healthcare costs and better resource utilization.

Key Challenge:

Technical Expertise and Training Requirements: One of the key problems of MIS is the high learning curve required to master the requisite techniques and abilities. Surgeons need specific training and skill to maneuver through smaller incisions with endoscopic equipment or robotic devices. Skill and hand-eye coordination in MIS are frequently different from those necessary in regular open surgery.

Equipment and Instrumentation Costs: The high cost of specialist equipment and instrumentation limits the deployment of MIS. Endoscopic cameras, laparoscopic equipment, robotic systems, and other technological breakthroughs utilized in MIS are costly to acquire, maintain, and upgrade. Hospitals and healthcare facilities must make large efforts to obtain these technology which might strain financial resources.

Complication Risk and Learning Curve Impact: Although MIS has lower complications and faster recovery periods than traditional open surgery, the move is not without dangers. The learning curve associated with implementing MIS procedures might lead to an increase in intraoperative problems such as unintentional organ injury, hemorrhage, or conversion to open surgery. Surgeons beginning their MIS careers may face difficulties in appropriately assessing anatomy and managing unexpected intraoperative findings through small incisions.

Key Trends:

Indication Expansion: Originally limited to operations such as appendectomies and cholecystectomies, MIS has now grown to include a wide range of surgical specialties. Complex treatments such as minimally invasive heart surgery (MICS), minimally invasive spine surgery, and robotic-assisted gynecological surgeries are already standard practice. The development of specialized devices and techniques targeted to distinct anatomical sites has increased the usefulness of MIS to a wide range of medical disorders.

Improved Patient Outcomes: Improved patient outcomes are a defining feature of MIS and continue to drive adoption. Reduced trauma to surrounding tissues, less postoperative pain, and faster recovery times all contribute to shorter hospital stays and cheaper healthcare expenditures. Compared to open operations, patients who undergo MIS frequently have less scarring and a lower risk of wound infections.

Training and Education: As MIS approaches advance, training and education have become major focal points. Surgeons require specific training to master minimally invasive techniques and skillfully manage technological innovations. Simulation-based training programs and virtual reality (VR) simulators are increasingly being used to give surgeons hands-on experience in a controlled environment prior to performing procedures on patients.

Global Minimally Invasive Surgery Market Regional Analysis

North America

North America leads the global minimally invasive surgeries (MIS) market which is seeing strong growth due to a number of major drivers. One critical issue is the growing frequency of chronic diseases throughout the region which range from cardiovascular disorders to orthopedic ailments and malignancies. As chronic illnesses become increasingly common, there is a greater desire for improved medical solutions that provide less invasive treatment choices. Minimally invasive operations which have smaller incisions, shorter recovery times, and a lower risk of problems than standard open surgeries are growing popular among both patients and healthcare practitioners.

The extensive use of minimally invasive operations in North America can be traced to a gradual shift in medical practice and patient preferences. Healthcare systems in the region are increasingly emphasizing the benefits of MIS which include shorter hospital stays, faster recovery times, and better cosmetic outcomes. These benefits not only improve patient satisfaction but also lead to cost savings in the healthcare system.

Furthermore, advances in surgical instruments, imaging technology, and robotics have greatly increased the scope and precision of MIS treatments making them appropriate for a wider range of medical disorders.

Europe

The European market for minimally invasive operations is expanding rapidly owing to considerable government backing aimed at promoting wider use throughout the area. European governments are actively encouraging minimally invasive procedures because of its multiple advantages such as faster recovery times, fewer risk of problems, and shorter hospital stays. These methods which use advanced technologies and techniques to perform surgeries through small incisions rather than traditional open surgery are becoming increasingly popular among healthcare providers and patients alike.

European government's assistance includes measures to improve healthcare professional training in minimally invasive treatments, money for medical device research and development, and incentives for hospitals to invest in cutting-edge surgical equipment. These efforts are intended to improve healthcare outcomes, optimize resource use within healthcare systems, and lower overall healthcare expenditures. As a result, the European market for minimally invasive operations is expected to grow further with advances in surgical instruments, imaging technology, and surgical robotics driving additional progress.

Global Minimally Invasive Surgery Market: Segmentation Analysis

The Global Minimally Invasive Surgery Market is segmented based on Type of Surgery, Applications, Product Type, and Geography.

Minimally Invasive Surgery Market, By Type of Surgery

• Surgical Instruments
• Robotics Systems
• Visualization Systems
• Accessories and Consumables

Based on Type of Surgery, the Global Minimally Invasive Surgery Market is bifurcated into Surgical Instruments, Robotics Systems, Visualization Systems, Accessories and Consumables. Robotic surgery is emerging as the dominant type within the minimally invasive surgery (MIS) market. Robotic systems offer surgeons enhanced precision, dexterity, and 3D visualization capabilities which are crucial for performing complex procedures with greater accuracy compared to traditional methods. These systems enable minimally invasive surgeries across various specialties including urology, gynecology, and general surgery, thereby expanding their applicability and adoption. Furthermore, robotic surgery platforms continue to evolve with advancements in artificial intelligence and machine learning promising even greater surgical outcomes and efficiency.

Minimally Invasive Surgery Market, By Application

• Gastrointestinal Surgery
• Cardiothoracic Surgery
• Orthopedic Surgery
• Gynecological Surgery

Based on Application, the Global Minimally Invasive Surgery Market is bifurcated into Gastrointestinal Surgery, Cardiothoracic Surgery, Orthopedic Surgery, and Gynecological Surgery. Among the listed applications, minimally invasive surgery (MIS) in orthopedic surgery stands out as particularly dominant. This dominance can be attributed to several factors. Advancements in arthroscopic techniques have revolutionized the treatment of orthopedic conditions like knee injuries, shoulder problems, and hip disorders. These procedures offer patients reduced recovery times, minimal scarring, and lower risks of infection compared to traditional open surgeries. Moreover, the aging population and increasing sports-related injuries have fueled the demand for orthopedic interventions that offer quicker rehabilitation and less post-operative pain. Overall, the combination of clinical effectiveness, patient preference for quicker recovery, and ongoing technological innovation positions orthopedic MIS as the dominant application within the broader MIS market landscape.

Minimally Invasive Surgery Market, By Product Type

• Surgical Instruments
• Robotics Systems
• Visualization Systems
• Accessories and Consumables

Based on Product Type, the Global Minimally Invasive Surgery Market is bifurcated into Surgical Instruments, Robotics Systems, Visualization Systems, Accessories and Consumables. In the minimally invasive surgery (MIS) market, surgical instruments dominate due to their essential role in performing precise and controlled procedures. These instruments including laparoscopic graspers, scissors, dissectors, and trocars are fundamental for manipulating tissues and organs through small incisions minimizing trauma and promoting quicker recovery times for patients. Surgical instruments are widely used across various specialties such as general surgery, gynecology, urology, and orthopedics contributing significantly to the overall adoption of minimally invasive techniques. Their versatility coupled with advancements in design and materials continually enhances surgical outcomes and patient safety.

Minimally Invasive Surgery Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Minimally Invasive Surgery Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. Among the regions mentioned, North America stands out as dominant in the minimally invasive surgery (MIS) market. The United States leads due to advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on technological innovation. The market in the US benefits from extensive research and development activities, favorable reimbursement policies, and a large patient pool opting for minimally invasive procedures. Overall, North America's dominance in the MIS market is bolstered by its robust healthcare system, technological advancements, and proactive government support.

Key Players

The "Global Minimally Invasive Surgery Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic plc, Johnson & Johnson, Stryker Corporation, Abbott Laboratories, Boston Scientific Corporation, Siemens Healthineers AG, Philips, GE Healthcare, Smith & Nephew plc, Zimmer Biomet Holdings, Inc., Olympus Corporation, Intuitive Surgical Inc., CONMED Corporation, and B. Braun Melsungen AG.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Minimally Invasive Surgery Market Key Developments

• In June 2022, Boston Scientific agreed to buy a controlling stake in M.I.Tech, a manufacturer and distributor of non-vascular metal stents used in endoscopic and urologic operations, from South Korea's Synergy Innovation. Boston Scientific offered about KRW 14,500 (about USD 11) per M.I.Tech share, for a total price of KRW 291.2, or around USD 230 million.
• In January 2024, PENTAX Medical received CE certification for its PENTAX Medical INSPIRA, a new premium video processor, and the i20c video endoscope series. The new video processor retains compatibility with PENTAX Medical's most recent endoscope models while also setting new standards with the new i20c video endoscope generation.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Minimally Invasive Surgery (MIS) Market , By Type of Surgery

• Laparoscopic Surgery
• Robotic Surgery
• Endoscopic Surgery
• Thoracoscopic Surgery

5. Minimally Invasive Surgery (MIS) Market, By Product Type

• Surgical Instruments
• Robotics Systems
• Visualization Systems
• Accessories and Consumables

6. Minimally Invasive Surgery (MIS) Market, By Application

• Gastrointestinal Surgery
• Cardiothoracic Surgery
• Orthopedic Surgery
• Gynecological Surgery

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic plc (Ireland)
• Johnson & Johnson (US)
• Stryker Corporation (US)
• Abbott Laboratories (US)
• Boston Scientific Corporation (US)
• Siemens Healthineers AG (Germany)
• Philips (Netherlands)
• GE Healthcare (US)
• Smith & Nephew plc (UK)
• Zimmer Biomet Holdings, Inc. (US)
• Olympus Corporation (Japan)
• Intuitive Surgical Inc. (US) (Focuses on robotic-assisted surgery)
• CONMED Corporation (US)
• B. Braun Melsungen AG (Germany)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References